FDA Inspection 1048948 — Tissue Transplant Technology, Ltd.

Tissue Transplant Technology, Ltd. — FEI 3000779542

The FDA completed an inspection of Tissue Transplant Technology, Ltd. on April 19, 2018 in San Antonio, TX. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
April 19, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
San Antonio, TX (United States)

Citations

IDCFRDescription
1232521 CFR 1271.160(b)(6)Deviations--evaluation, cause, corrective action
1239521 CFR 1271.225Verification/validation
1240321 CFR 1271.230(c)Change activities documented